Position in ZTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$103,278,126
-$42,003,027 QoQ
Shares Held
1,437,213
+16.9% QoQ
Ownership
0.348%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#55
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 39%
Shared 0%
None 61%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
1,437,213 | $103,278,126 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
120,078 | $65,061,862 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
312,832 | $52,724,705 | |
| 4 | VTRS |
Viatris Inc
|
2,872,464 | $45,614,728 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,264,159 | $31,110,952 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
633,778 | $21,973,083 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
197,060 | $21,861,836 | |
| 8 | ALKS |
Alkermes plc.
|
387,999 | $20,331,147 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,278,126 | 1,437,213 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $145,281,153 | 1,229,009 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $154,115,408 | 1,224,888 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $163,070,274 | 1,114,477 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $170,350,578 | 1,092,341 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $183,552,478 | 1,114,804 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $173,211,045 | 1,063,101 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $207,608,052 | 1,062,586 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $190,003,773 | 1,096,007 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $187,866,248 | 1,110,255 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $204,902,033 | 1,038,162 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $182,621,760 | 1,049,671 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $176,946,980 | 1,027,507 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $173,375,055 | 1,041,667 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $149,920,210 | 1,022,997 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $145,110,662 | 978,560 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $167,487,725 | 974,389 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $172,057,634 | 912,337 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $219,067,927 | 897,709 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $172,563,280 | 888,860 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $169,340,113 | 908,672 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $151,699,381 | 963,293 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $161,724,448 | 977,187 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $162,866,794 | 984,863 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $139,942,370 | 1,021,179 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $119,114,402 | 1,012,103 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||